The 21st Annual Healthcare Summit 

The Future of Innovation, Personalized Medicine and Genomics

October 21-22, 2021, Vancouver, BC

Sustaining the Momentum for ChangeInnovation to Implementation

21st ANNUAL HEALTHCARE SUMMIT 

FALL 2021

Sustaining the Momentum for Change: Innovation to Implementation

The 2021 Annual Healthcare Summit Hybrid 

Two Simultaneous Events

  • The Digital-First Virtual Experience
  • In-Person Experience by invitation

OCT
21–22

Listen.

Learn.

Implement.

$

Earlybird Registration Now Open

Earlybird Pricing Ends In

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Earlybird Registration – until Aug.15th

$249.00 CAD (plus GST)

After August 15th $299.00 CAD (plus GST)

About The 2021 Summit

Sustaining the Momentum for Change: Innovation to Implementation
The 21st Annual Healthcare Summit brings together national and international healthcare leaders to connect, educate and discuss new strategies that drive innovation and lead to future implementation of transformative healthcare.

The 2021 hybrid summit will include both our “Digital First” custom-designed virtual platform with up to 1000 delegates and 100 invited delegates at our in-person (subject to provincial guidelines) event experience at the Coast Coal Harbour Hotel in Vancouver, BC.

Over 50 subject matter experts in the fields of digital health technology, personalized medicine, health innovation, value-based healthcare and genomics discuss the most relevant topics on the rapid acceleration towards digital healthcare.

Dr. Jehannine Austin

Dr. Jehannine Austin is Executive director of the BC Mental Health and Substance Use Services Research Institute, and is a Professor in Psychiatry & Medical Genetics at the University of British Columbia. Jehannine is a board certified genetic counsellor and their research work involves studying the impact of genetic counselling for people with psychiatric disorders and their families. They founded the world’s first specialist psychiatric genetic counselling service that has won an award for its impact on patient outcomes, and in addition to peer-reviewed publications, has written a book, and won awards for teaching, leadership, and research. Together with Prof. Stirling Bryan, Jehannine is co-PI of a Genome Canada/Genome BC/MSFHR funded project that is exploring the health economics of pharmacogenetic testing for depression in BC. Jehannine is a member of the College of the Royal Society of Canada, and a Fellow of the Canadian Academy of Health Sciences.

 

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Arden Krystal

President and CEO of Southlake Regional Health Centre in Newmarket, Ontario.

Arden Krystal is the President and CEO of Southlake Regional Health Centre in Newmarket, Ontario. Southlake serves a population of almost 1.5 million people in York Region and Simcoe county, with regional cancer and cardiac programs and a full slate of services from surgery to mental health to children’s and women’s care.

 

Prior to her arrival at Southlake, Ms. Krystal held senior executive operations roles at two of the largest health authorities in British Columbia – the Fraser Health Authority and the Provincial Health Services Authority, with responsibilities spanning the full continuum of care, including public health, acute community, tertiary care, and quaternary research and academic organizations. Her portfolios also included responsibility for non-clinical services, such as quality, risk and human resources, as well as executive leadership for major public-private partnership (P3) capital projects in the hospital sector.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

HANDOL KIM

Co-Founder & CEO, Variational AI.

Handol is Co-Founder & CEO of Variational AI, an AI for drug discovery start-up based in Vancouver. Variational AI is applying its state-of-the-art generative AI to generate novel drug-like small molecules that are efficacious, safe, and synthesizable in months versus years. Handol  brings over 20 years of executive management experience and leadership from venture-backed start-ups and publicly-listed technology companies in cloud, mobile/embedded, and telecommunications software in Silicon Valley, Canada, and Asia Pacific. 

Handol serves on the boards of AI Network of British Columbia (AInBC), the Digital Technology Supercluster, and the United Way British Columbia.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Dr. Marc Fiume

CEO DNAstack 

Marc is an advocate for privacy, security, and sharing of genomic datasets, guiding the DNAstack team’s efforts to making genomic and clinical information globally accessible and useful. Through his leadership, DNAstack’s Beacon Network has become the world’s largest search engine for publicly sharing genomic mutations, facilitating millions of searches and resulting in disease-gene discoveries and clinical translation. Marc leads the Discovery Work Stream for the Global Alliance for Genomics & Health (GA4GH), chairing the development of the Beacon genomic data standard for search and co-founded the Canadian Genomics Cloud. 

Join us for two days of panels  & keynotes

DAYS UNTIL SUMMIT

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

OCTOBER 21

THURS

4 Keynotes

24 Speakers

6 Panels

OCTOBER 22

FRI

2 Keynotes

28 Speakers

7 Panels

Request Invite to the In-Person Event

1 + 15 =

Book a Seat 

“Digital First Experience” Our custom-designed virtual platform 

Topics that will be discussed:

  • Virtual Care – “Equity, Diversity and Inclusion”
  • Artificial Intelligence, Analytics and Machine Learning
  • Modern Data Protection – “Most Sensitive and Valuable Data”
  • Personalized Medicine – “A New Era in Genetic Medicine”
  • Value-Based Healthcare – “A New Model Focused on Accountability
  • Consumer Based Healthcare – “Focused on the Patient”
  • Phamacogenomics – “The Right Medication for You”
  • Vaccine Passports – “Leading with Privacy”

Target Audience:

  • Federal, provincial and regional healthcare officials
  • Senior policy makers
  • Intelligence and technology officials
  • Academics
  • Healthcare professionals

.

$

HCS COM

Join our newsletter

News & Updates